Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

c-MYC inhibits differentiation and regulates the process by which cells acquire biomass, cell growth. Down-regulation of c-MYC, reduced cell growth, and decreased activity of the PI3K/AKT/mTORC1 signal transduction pathway are features of the terminal differentiation of committed myeloid precursors to polymorphonuclear neutrophils. Since mTORC1 regulates growth, we hypothesized that pharmacological inhibition of mTORC1 by rapamycin may reverse the phenotypic effects of c-MYC. Here we show that granulocytes blocked in their ability to differentiate by enforced expression of c-MYC can be induced to differentiate by reducing exogenous c-MYC expression through rapamycin treatment. Rapamycin also reduced expression of endogenous c-MYC and resulted in enhanced retinoid-induced differentiation. Total cellular c-Myc mRNA and c-MYC protein stability were unchanged by rapamycin, however the amount of c-Myc mRNA associated with polysomes was reduced. Therefore rapamycin limited expression of c-MYC by inhibiting c-Myc mRNA translation. These findings suggest that mTORC1 could be targeted to promote terminal differentiation in myeloid malignancies characterized by dysregulated expression of c-MYC.

[1]  P. Houghton,et al.  mTOR as a Target for Cancer Therapy , 2008 .

[2]  P. Knoepfler.  Myc goes global: new tricks for an old oncogene. , 2007, Cancer research.

[3]  D. Sabatini,et al.  Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. , 2007, Blood.

[4]  R. Eisenman,et al.  The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. , 2007, Genes & development.

[5]  T. Haritunians,et al.  Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma , 2007, Leukemia.

[6]  R. Vartanian,et al.  Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling , 2006, Oncogene.

[7]  M. Konopleva,et al.  Phase I/II Study of the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Patients with Relapsed or Refractory Hematologic Malignancies , 2006, Clinical Cancer Research.

[8]  Yi Wen Kong,et al.  Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. , 2006, Molecular cell.

[9]  Kathryn A. O’Donnell,et al.  The c-Myc target gene network. , 2006, Seminars in cancer biology.

[10]  A. W. Harris,et al.  MYC levels govern hematopoietic tumor type and latency in transgenic mice. , 2006, Blood.

[11]  Philip R. Gafken,et al.  Myc influences global chromatin structure , 2006, The EMBO journal.

[12]  M. Carroll,et al.  mTOR regulates cell survival after etoposide treatment in primary AML cells. , 2005, Blood.

[13]  M. Tomasson,et al.  c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. , 2005, Blood.

[14]  M. Eilers,et al.  Transcriptional regulation and transformation by Myc proteins , 2005, Nature Reviews Molecular Cell Biology.

[15]  A. W. Harris,et al.  T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC , 2005, Oncogene.

[16]  S. Janz.  Uncovering MYC's full oncogenic potential in the hematopoietic system , 2005, Oncogene.

[17]  P. Gaines,et al.  Heterogeneity of functional responses in differentiated myeloid cell lines reveals EPRO cells as a valid model of murine neutrophil functional activation , 2005, Journal of leukocyte biology.

[18]  M. Hall,et al.  The expanding TOR signaling network. , 2005, Current opinion in cell biology.

[19]  Joseph Gera,et al.  Cyclin D1 and c-myc Internal Ribosome Entry Site (IRES)-dependent Translation Is Regulated by AKT Activity and Enhanced by Rapamycin through a p38 MAPK- and ERK-dependent Pathway* , 2005, Journal of Biological Chemistry.

[20]  H. Lane,et al.  The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation , 2005, Cell.

[21]  G. Laurent,et al.  Antileukemic activity of rapamycin in acute myeloid leukemia. , 2005, Blood.

[22]  Lars-Gunnar Larsson,et al.  c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription , 2005, Nature Cell Biology.

[23]  B. Edgar,et al.  Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development , 2005, Nature Cell Biology.

[24]  Carla Grandori,et al.  c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I , 2005, Nature Cell Biology.

[25]  H. Lane,et al.  The mTOR Inhibitor RAD 001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p 21 Translation , 2005 .

[26]  Kazuhide Inoue,et al.  Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. , 2004, Biochemical pharmacology.

[27]  R. Pearson,et al.  MAD1 and c‐MYC regulate UBF and rDNA transcription during granulocyte differentiation , 2004, The EMBO journal.

[28]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[29]  P. Sarnow,et al.  Preferential Translation of Internal Ribosome Entry Site-containing mRNAs during the Mitotic Cycle in Mammalian Cells* , 2004, Journal of Biological Chemistry.

[30]  M. James,et al.  Phosphatidylinositol 3-Kinase and mTOR Signaling Pathways Regulate RNA Polymerase I Transcription in Response to IGF-1 and Nutrients* , 2004, Journal of Biological Chemistry.

[31]  I. Grummt,et al.  mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. , 2004, Genes & development.

[32]  I. Mellinghoff,et al.  AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression* , 2004, Journal of Biological Chemistry.

[33]  D. Sabatini,et al.  Raptor and mTOR: subunits of a nutrient-sensitive complex. , 2004, Current topics in microbiology and immunology.

[34]  Ying Qi,et al.  Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization* , 2003, Journal of Biological Chemistry.

[35]  T. S. Kim,et al.  Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin. , 2003, European journal of pharmacology.

[36]  J. Cheong,et al.  Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia. , 2003, Leukemia research.

[37]  R. Pearson,et al.  mTOR-Dependent Regulation of Ribosomal Gene Transcription Requires S6K1 and Is Mediated by Phosphorylation of the Carboxy-Terminal Activation Domain of the Nucleolar Transcription Factor UBF† , 2003, Molecular and Cellular Biology.

[38]  K. Saeki,et al.  Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce cell cycle progression through the synthesis of c-Myc protein by internal ribosome entry site-mediated translation via phosphatidylinositol 3-kinase pathway in human factor-dependent leukemic cells. , 2003, Blood.

[39]  M. Carroll,et al.  Survival of acute myeloid leukemia cells requires PI3 kinase activation. , 2003, Blood.

[40]  T. Hayakawa,et al.  The role of c-Myc on granulocyte colony-stimulating factor-dependent neutrophilic proliferation and differentiation of HL-60 cells. , 2003, Biochemical pharmacology.

[41]  Andrea Cocito,et al.  Genomic targets of the human c-Myc protein. , 2003, Genes & development.

[42]  J. Cheong,et al.  Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable , 2003, Leukemia.

[43]  Michael N. Hall,et al.  TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.

[44]  R. Eisenman,et al.  Direct activation of RNA polymerase III transcription by c-Myc , 2003, Nature.

[45]  D. Levens,et al.  Reconstructing MYC. , 2003, Genes & development.

[46]  C. Bloomfield,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol , 2022 .

[47]  S. Collins.  The role of retinoids and retinoic acid receptors in normal hematopoiesis , 2002, Leukemia.

[48]  T. Hayakawa,et al.  Role of the p70 S6 kinase cascade in neutrophilic differentiation and proliferation of HL-60 cells-a study of transferrin receptor-positive and -negative cells obtained from dimethyl sulfoxide- or retinoic acid-treated HL-60 cells. , 2002, Archives of biochemistry and biophysics.

[49]  J. Griffin,et al.  The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.

[50]  P. Chambon,et al.  Down-regulation of the Phosphatidylinositol 3-Kinase/Akt Pathway Is Involved in Retinoic Acid-induced Phosphorylation, Degradation, and Transcriptional Activity of Retinoic Acid Receptor γ2* , 2002, The Journal of Biological Chemistry.

[51]  J. Griffin,et al.  Role of FLT3 in leukemia. , 2002, Current opinion in hematology.

[52]  T. Moss,et al.  At the Center of Eukaryotic Life , 2002, Cell.

[53]  Barbara Hoffman,et al.  The proto-oncogene c-myc in hematopoietic development and leukemogenesis , 2002, Oncogene.

[54]  G. Evan,et al.  Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression , 2002, Cell.

[55]  James M. Roberts,et al.  MAD1 and p27KIP1 Cooperate To Promote Terminal Differentiation of Granulocytes and To Inhibit Myc Expression and Cyclin E-CDK2 Activity , 2002, Molecular and Cellular Biology.

[56]  Hua Tang,et al.  Amino Acid-Induced Translation of TOP mRNAs Is Fully Dependent on Phosphatidylinositol 3-Kinase-Mediated Signaling, Is Partially Inhibited by Rapamycin, and Is Independent of S6K1 and rpS6 Phosphorylation , 2001, Molecular and Cellular Biology.

[57]  T Subkhankulova,et al.  Internal ribosome entry segment-mediated initiation of c-Myc protein synthesis following genotoxic stress. , 2001, The Biochemical journal.

[58]  A. Gingras,et al.  The target of rapamycin (TOR) proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Y. Honma,et al.  Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. , 2001, Experimental hematology.

[60]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[61]  M Schwab,et al.  N‐myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis , 2001, The EMBO journal.

[62]  J. Kutok,et al.  Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3. , 2001, Blood.

[63]  M. Brink,et al.  Translation Initiation of the Insulin-like Growth Factor I Receptor mRNA Is Mediated by an Internal Ribosome Entry Site* , 2001, The Journal of Biological Chemistry.

[64]  R. Eisenman,et al.  Deconstructing myc. , 2001, Genes & development.

[65]  D. Gilliland.  Hematologic malignancies. , 2001, Current opinion in hematology.

[66]  T. P. Neufeld,et al.  Regulation of cellular growth by the Drosophila target of rapamycin dTOR. , 2000, Genes & development.

[67]  N. Lee,et al.  Identification of c-myc responsive genes using rat cDNA microarray. , 2000, Cancer research.

[68]  Tobias Schmelzle,et al.  TOR, a Central Controller of Cell Growth , 2000, Cell.

[69]  C. Dang,et al.  Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Lanotte,et al.  Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. , 2000, Blood.

[71]  B. Hoffman,et al.  p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation , 2000, Oncogene.

[72]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Dickens,et al.  c-Myc Protein Synthesis Is Initiated from the Internal Ribosome Entry Segment during Apoptosis , 2000, Molecular and Cellular Biology.

[74]  T. Hayakawa,et al.  Commitment of Neutrophilic Differentiation and Proliferation of HL-60 Cells Coincides with Expression of Transferrin Receptor , 1999, The Journal of Biological Chemistry.

[75]  C. Morris,et al.  Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. , 1999, Cancer genetics and cytogenetics.

[76]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[77]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[78]  D. Felsher,et al.  Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[79]  L. Campbell,et al.  MYC amplification in two further cases of acute myeloid leukemia with trisomy 4 and double minute chromosomes. , 1999, Cancer genetics and cytogenetics.

[80]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[81]  B. Safer,et al.  Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation. , 1999, The Biochemical journal.

[82]  E. Gelfand,et al.  Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. Gingras,et al.  The mRNA 5' cap-binding protein eIF4E and control of cell growth. , 1998, Current opinion in cell biology.

[84]  R. Hannan,et al.  Transcription by RNA polymerase I. , 1998, Frontiers in bioscience : a journal and virtual library.

[85]  G. Thomas,et al.  TOR signalling and control of cell growth. , 1997, Current opinion in cell biology.

[86]  R. Pearson,et al.  Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.

[87]  B. Hoffman,et al.  Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells. , 1995, Oncogene.

[88]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[89]  S. Collins,et al.  A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  R. Warrell,et al.  Acute promyelocytic leukemia. , 1993, The New England journal of medicine.

[91]  A. Bradley,et al.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. , 1993, Genes & development.

[92]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[93]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[94]  S. Schreiber,et al.  Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.

[95]  J. Bishop,et al.  The MYC protein activates transcription of the alpha‐prothymosin gene. , 1991, The EMBO journal.

[96]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[97]  M. Cole.  The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.

[98]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.

[99]  A. Chapelle,et al.  ACUTE MYELOGENOUS LEUKAEMIA WITH C-MYC AMPLIFICATION AND DOUBLE MINUTE CHROMOSOMES , 1985, The Lancet.

[100]  L. Hillestad,et al.  Acute promyelocytic leukemia. , 2009 .